Learn about common side effects of radioligand therapy for metastatic prostate cancer and effective strategies to manage them for better outcomes.

PSMA therapy is a targeted treatment for metastatic prostate cancer that uses radioligand therapy to slow disease progression and improve quality of life.

A three-point scoring system that requires nothing more than a blood count, a brief assessment of a patient’s physical ...

Sept. 18, 2025 -- About 1 in 8 men will face a prostate cancer diagnosis. Early-stage prostate cancer often has no symptoms—so how should men approach screening and advocacy? What disparities do Black ...

When prostate cancer spreads beyond the prostate gland to other parts of the body, it becomes what medical professionals call metastatic prostate cancer. This advanced form of the disease represents a ...

In patients with oligometastatic prostate cancer, metastasis-directed therapy plus standard of care was associated with significant improvements in progression-free survival (PFS), radiographic PFS, ...

A new treatment approved by the FDA in June is giving certain men with advanced prostate cancer another treatment option.

Bob Lane discusses his experience with prostate cancer, and describes what survivorship and cure means to him as someone living with metastatic disease. The word ‘cure’ and the aspects or survivorship ...

The spread of cancer from a primary tumor to another place in the body, called metastasis, remains one of the greatest ...

Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and ...